UA109581C2 - COMPOUNDS WITH THE ACTIVITY OF MUSCARIN RECEPTORS ANGONISTS AND BET2 ADRENERGY RECEPTOR AGONISTS - Google Patents

COMPOUNDS WITH THE ACTIVITY OF MUSCARIN RECEPTORS ANGONISTS AND BET2 ADRENERGY RECEPTOR AGONISTS

Info

Publication number
UA109581C2
UA109581C2 UAA201314286A UAA201314286A UA109581C2 UA 109581 C2 UA109581 C2 UA 109581C2 UA A201314286 A UAA201314286 A UA A201314286A UA A201314286 A UAA201314286 A UA A201314286A UA 109581 C2 UA109581 C2 UA 109581C2
Authority
UA
Ukraine
Prior art keywords
compounds
receptor agonists
adrenergy
angonists
bet2
Prior art date
Application number
UAA201314286A
Other languages
Russian (ru)
Ukrainian (uk)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2012/060795 external-priority patent/WO2012168359A1/en
Application filed filed Critical
Publication of UA109581C2 publication Critical patent/UA109581C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Даний винахід стосується сполук, діючих як антагоністи мускаринових рецепторів, так і як агоністи адренергічного рецептора бета2, способів їх отримання, композицій, що включають їх, терапевтичних застосувань і комбінацій з іншими фармацевтично активними інгредієнтами.The present invention relates to compounds that act as muscarinic receptor antagonists as well as beta-2 adrenergic receptor agonists, methods for their preparation, therapeutic compositions and combinations with other pharmaceutically active ingredients.

UAA201314286A 2011-06-10 2012-07-06 COMPOUNDS WITH THE ACTIVITY OF MUSCARIN RECEPTORS ANGONISTS AND BET2 ADRENERGY RECEPTOR AGONISTS UA109581C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11169537 2011-06-10
PCT/EP2012/060795 WO2012168359A1 (en) 2011-06-10 2012-06-07 Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity

Publications (1)

Publication Number Publication Date
UA109581C2 true UA109581C2 (en) 2015-09-10

Family

ID=54772491

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201314286A UA109581C2 (en) 2011-06-10 2012-07-06 COMPOUNDS WITH THE ACTIVITY OF MUSCARIN RECEPTORS ANGONISTS AND BET2 ADRENERGY RECEPTOR AGONISTS

Country Status (1)

Country Link
UA (1) UA109581C2 (en)

Similar Documents

Publication Publication Date Title
EA201391662A1 (en) CONNECTIONS WITH THE ACTIVITY OF ANTAGONISTS OF MUSCARINE RECEPTORS AND AGONISTS OF THE ADRENERGIC RECEPTOR BETA2
EA201590873A1 (en) Compounds possessing the activity of antagonists of muscarinic receptors and agonists of beta2 adrenergic receptors
BR112015012746A2 (en) compounds having muscarinic receptor antagonist and beta2-adrenergic receptor agonist activity
PH12017501424B1 (en) Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity
EA201290940A1 (en) NEW CONNECTIONS AS SELECTIVE ANTAGONISTS OF NK3 RECEPTOR, PHARMACEUTICAL COMPOSITION AND METHODS OF THEIR USE FOR DAMAGE MEDIATED BY NK3 RECEPTORS
EA201690033A2 (en) MORPHINAN COMPOUNDS
CL2013000732A1 (en) Compounds derived from buprenorphine analogs, with activity as agonists and / or opioid receptor antagonists; composition that understands them; its method of preparation; and its use for the treatment or prevention of pain or constipation.
EA201690006A1 (en) DRY POWDER COMPOSITION CONTAINING ANTICHOLINERGIC AGENT, CORTICOSTEROIDS AND BETA ADRENERGIC AGENT FOR INTRODUCTION BY INHALATION
EA201400567A1 (en) NEW CYCLOGEXYLAMINE DERIVATIVES THAT HAVE AN AGONISTIC ACTIVITY WITH RESPECT TO β2 ADRENERGIC RECEPTOR AND ANTAGONISTIC ACTIVITY WITH RESPECT TO MUSCARINO RECEPTOR
EA201100161A1 (en) QUINUCLIDINE CARBONATE DERIVATIVES AND THEIR MEDICAL COMPOSITIONS
EA201490037A1 (en) ANTAGONISTS TRPV4
EA201500651A1 (en) NEW DERIVATIVES AND cyclohexyl- HINUKLIDINILKARBAMATA having agonistic activity towards β2 adrenergic receptor and antagonistic activity against muscarinic receptors M3
MX2013006418A (en) Oxazolyl-methylether derivatives as alx receptor agonists.
EA201401259A1 (en) FLUORINATED BRIDGES DERIVATIVES OF SPIRO [2,4] HEPTANA AS AGONISTS OF ALX RECEPTOR
EA201491153A1 (en) COMPOSITIONS OF BUPRENORPHINE AND ANTAGONISTS OF μ-OPIOID RECEPTORS
JO3128B1 (en) Deuterated 1-piperazino-3-phenyl-indanes for treatment of schizophrenia
EA201001842A1 (en) NEW CONNECTIONS WITH THE ACTIVITY OF ANTAGONISTS OF MUSCARINE RECEPTORS
MX2017015047A (en) Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity.
EA201490938A1 (en) SPIROTHYENE-PYRANIPIPERIDINE DERIVATIVES AS ANTAGONISTS OF ORL-1 RECEPTOR FOR USE TO TREAT ALCOHOL DEPENDENCE AND ABUSE OF ALCOHOL
BR112013025682A2 (en) COMPOUNDS, PHARMACEUTICAL COMPOSITION, USE OF A COMPOUND, COMBINATION AND DEVICE
UA109581C2 (en) COMPOUNDS WITH THE ACTIVITY OF MUSCARIN RECEPTORS ANGONISTS AND BET2 ADRENERGY RECEPTOR AGONISTS
TN2013000429A1 (en) Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity
UA108104C2 (en) Derivative of cyclohexylamine having b2 adrenergic receptors adrenergic agonist and m3 muscarinic antagonist activity